Standardised vs Raw Tongkat Ali: What Singapore Buyers Need to Understand

What Is Actually Inside Tongkat Ali?

Eurycoma longifolia is, chemically speaking, a remarkably complex plant. Its bioactive profile includes several classes of compounds that have been the subject of increasing scientific scrutiny over the past two decades. Understanding which of these compounds does what — and why their concentrations matter — is the foundation of everything that follows.

Eurycomanone

Eurycomanone is the headline compound. A quassinoid — a class of highly oxygenated terpenoid — eurycomanone is the primary bioactive responsible for the testosterone-modulating and aphrodisiac properties that Tongkat Ali is best known for. Its mechanism of action involves the inhibition of sex hormone-binding globulin (SHBG), which effectively increases the proportion of free testosterone circulating in the bloodstream. It also appears to stimulate steroidogenesis at the level of the steroidogenic acute regulatory (StAR) protein, which controls the rate-limiting step in testosterone biosynthesis.

A landmark paper by Low et al. (2013) published in the Journal of Ethnopharmacology characterised this pathway in detail, establishing eurycomanone as the principal mediator of Tongkat Ali's androgenic effects. The critical clinical implication: without measurable eurycomanone content, a Tongkat Ali product has no reliable androgenic mechanism.

Eurypeptides

Eurypeptides — a class of small glycoproteins unique to Eurycoma longifolia — represent the second major bioactive category and are, I would argue, underappreciated in popular discussion. These peptides have demonstrated adaptogenic properties: specifically, the ability to modulate the hypothalamic-pituitary-adrenal (HPA) axis by reducing cortisol output under physiological stress.

Talbott et al.'s 2013 randomised controlled trial in the Journal of the International Society of Sports Nutrition found that a standardised extract containing both eurycomanone and intact eurypeptides produced a 16% reduction in cortisol and a 37% increase in testosterone in moderately stressed subjects — a synergistic hormonal effect that reflects the dual bioactive profile of a well-prepared extract.

Critically, eurypeptides are heat-sensitive proteins. This biological fragility has enormous implications for how the plant is processed.

Polysaccharides

Polysaccharides — long-chain water-soluble carbohydrates — form a substantial fraction of a properly prepared aqueous Tongkat Ali extract, including Physta®. While polysaccharide content is sometimes exploited as a cheap proxy standardisation marker in commodity supplements (a point worth flagging separately), the actual polysaccharide fraction in a well-characterised standardised extract is biologically meaningful in its own right. The published mechanistic literature on Tongkat Ali has associated this fraction with anti-fatigue and immunomodulatory activity, contributing to the herb's broader adaptogenic profile beyond the headline androgenic action of the quassinoids.

The Henkel et al. (2014) trial in Phytotherapy Research on Physta® at 400 mg/day documented improvements in muscular force, physical performance, and immune parameters in physically active older adults — outcomes the published characterisation attributes to the polysaccharide and glycosaponin fractions acting alongside eurycomanone, not to eurycomanone alone. Like the eurypeptides, the polysaccharide fraction depends on aqueous extraction with low-temperature drying for preservation; ethanol extraction strips most of it out.

Glycosaponins

Glycosaponins — triterpenoid saponins conjugated with sugar moieties, specific to Eurycoma longifolia — represent the largest bioactive fraction by mass in a properly characterised standardised Tongkat Ali extract. Physta® is standardised to greater than 40% glycosaponins by dry weight, sitting alongside its 0.8–1.5% eurycomanone and >22% bioactive-peptide content. The published mechanistic literature associates the glycosaponin fraction with support of androgen-receptor signalling and anabolic activity at the cellular level — a pathway distinct from, but complementary to, eurycomanone's SHBG-inhibiting and StAR-stimulating mechanism.

The Tambi et al. (2012) randomised controlled trial in Andrologia on standardised Physta® reported testosterone restoration in subjects with late-onset hypogonadism — an outcome attributed in the published characterisation to the combined action of eurycomanone, eurypeptides, and the glycosaponin fraction operating in concert rather than to any single compound. The clinical implication: a Tongkat Ali product lacking the glycosaponin fraction may carry only a portion of the full extract's potency, even when its eurycomanone content on its own appears acceptable.

The picture that emerges is of a plant whose clinical value is not attributable to a single molecule but to a carefully preserved ensemble of biochemically active compounds — each with its own stability profile, each requiring specific conditions to survive from root to capsule with potency intact.

Raw Root and Traditional Decoction: Why the Old Way Was Not Wrong — But Was Inconsistent

The traditional preparation of boiling Tongkat Ali — simmering sliced dried root in water for 20 to 40 minutes, producing a characteristically bitter, dark amber tea — is, from a biochemical standpoint, a crude but functionally valid extraction method.

Hot water does solubilise eurycomanone and, to some degree, eurypeptides. The bitter taste Tongkat Ali is famous for is itself a proxy marker for quassinoid content: the more intensely bitter the decoction, the higher the eurycomanone concentration. Traditional users knew this empirically, adjusting root quantity and simmering time to taste.

The problem is not that the method is ineffective. It is that it is irreproducibly variable in ways that matter enormously for consistent therapeutic use.

Raw Tongkat Ali root quality varies dramatically based on the age of the plant at harvest (roots require a minimum of four to six years of growth to accumulate meaningful quassinoid concentrations, with older roots — eight to ten years — considered premium), the geographical origin (Malaysian Eurycoma longifolia tends to have higher eurycomanone concentrations than Indonesian variants, though this is debated), seasonal variation in soil composition, post-harvest storage conditions, and the presence or absence of adulterants and heavy metals absorbed from the soil environment.

A 2020 study published in Industrial Crops and Products by Mohd Yusoff et al. analysed eurycomanone content across wild-harvested Tongkat Ali roots from five different Malaysian forest locations and found concentration variability of up to 340% between samples. The same root species, harvested from adjacent forest plots, could yield a decoction containing 0.1% eurycomanone or 0.8% eurycomanone depending on factors entirely invisible to the consumer.

This variability is the central argument for standardisation — and it is a scientific argument, not a commercial one. When your grandfather's bitter tonic worked reliably, he was lucky enough to consistently access high-quality root, probably from a trusted source who knew what good Tongkat Ali looked, felt, and tasted like. That artisanal quality control is not scalable to a modern supplement market serving millions of consumers. Standardisation is the industrial solution to the problem of biological variability.

Hot Water Extraction: The Science of Getting It Right

The extraction process is where the chemistry of Tongkat Ali either survives or is destroyed, and understanding it is crucial for evaluating any product claiming clinical relevance.

The most validated process for standardised Tongkat Ali extract is aqueous (hot water) extraction. The process used by Biotropics Malaysia to produce Physta®, the most extensively clinically studied extract, involves extracting root material in water at controlled temperature and pH parameters, freeze-drying the resulting liquid to a powder, and characterising the final product for eurycomanone content and eurypeptide biomarker levels. The freeze-drying step — lyophilisation — is critical for preserving the eurypeptides, which would be denatured by the high temperatures of spray-drying or other conventional drying methods.

This is why extraction method is not a minor technical footnote. It determines whether the eurypeptides — those HPA-axis modulating, cortisol-reducing proteins — survive at all. A product manufactured using spray-drying at high temperatures may retain acceptable eurycomanone levels while destroying substantially all of the eurypeptide fraction, producing a product with partial rather than full-spectrum bioactivity. The consumer has no way to identify this from the label unless the manufacturer explicitly discloses the drying method and provides eurypeptide biomarker data alongside eurycomanone content.

Some manufacturers use ethanol extraction rather than aqueous extraction, reasoning that alcohol is a more efficient solvent for certain quassinoids. The resulting extracts may show higher eurycomanone concentrations on paper. However, ethanol extraction removes the water-soluble eurypeptides almost entirely — they are not soluble in alcoholic solvents.

An ethanol extract of Tongkat Ali is a narrower product: potentially more potent for testosterone-specific endpoints, but without the adaptogenic cortisol-modulating properties that the peer-reviewed clinical evidence most consistently supports. The consumer buying an ethanol extract is not buying the same product tested in the RCTs. They may be buying something with less total evidence, at a dose extrapolated from studies on a chemically distinct preparation.

Why Standardisation Matters for Consistency — And What "Standardised" Actually Means

The word "standardised" appears on many supplement labels. Like "natural," it has been so liberally applied that it has lost much of its communicative value. A genuinely standardised extract, in the clinical pharmacology sense, means a product characterised for specific bioactive compounds at a defined minimum threshold, reproducible batch-to-batch within acceptable tolerance ranges, and validated against that specification by independent third-party analysis.

For Tongkat Ali, the most clinically validated standard is a eurycomanone content of ≥0.8% by dry weight in the final extract, combined with confirmed eurypeptide presence above a defined biomarker threshold. This is the specification that the Physta® and LJ100® extracts — the two most studied standardised Tongkat Ali products globally — are built around. Every clinical trial producing positive results for testosterone support, cortisol reduction, and male reproductive health has been conducted on extracts meeting or exceeding this specification.

A product labelled "standardised to 20% polysaccharides" or "standardised to 100 mg of active fraction" is using the language of standardisation without providing the relevant bioactive specification. Polysaccharide content is a proxy for general plant material presence, not a marker of hormonal or adaptogenic activity. This distinction matters because it is frequently exploited in marketing: a manufacturer can technically claim standardisation while standardising to an irrelevant compound.

The majority of "standardised" Tongkat Ali products currently available on Shopee, Lazada, and even mainstream pharmacy shelves in Singapore do not meet the ≥0.8% eurycomanone specification of the clinically studied extracts. Many are standardised to proxy markers. Some are not meaningfully standardised at all. The clinical evidence for Tongkat Ali that Singaporean consumers are responding to was generated on a specific, well-characterised product. Most consumers are not buying that product. They are buying something that shares a name and a label.

A Note on Extract Ratios: Why "1:200" Is Not a Quality Signal

Before going further, a separate point on extract ratios is worth making, because it intersects with the standardisation question and is one of the most common consumer misconceptions in this category. An extract ratio such as 1:50, 1:100, or 1:200 means that 50 kg, 100 kg, or 200 kg of raw root were processed to yield 1 kg of finished extract. Consumer intuition treats a higher ratio as a sign of greater potency. The reality runs in the opposite direction more often than buyers realise. Extract ratios are largely marketing jargon: a 1:200 ratio simply means a large quantity of raw root was processed down into a small quantity of extract, which can just as easily reflect low-quality starting material, aggressive processing that destroys fragile bioactives like eurypeptides, or simple over-concentration as it can reflect genuine potency. A 1:200 ethanol extract of poor source root, dried at high temperatures, can contain less effective bioactive content than a 1:20 freeze-dried aqueous extract of high-quality root with eurypeptides intact. Notably, Physta® itself sits at an extraction ratio in the region of 1:20 or less, deliberately, because its potency derives from preserving and standardising the bioactive ensemble rather than from maximising the headline ratio. The ratio is not the figure to look for. Eurycomanone percentage and eurypeptide biomarker confirmation are.

Implications for Effectiveness: Why You Might Feel Nothing

Eurycomanone's oral bioavailability in a poorly formulated product is limited by inconsistent particle size, lack of protective encapsulation, and interactions with other plant matrix compounds that vary with raw material source. A properly manufactured standardised extract controls these variables through defined extraction parameters and encapsulation technology. A raw root powder in a capsule controls nothing except what the plant happened to contain on the day it was ground.

The clinical consequence is not merely that consumers waste money. It is that a genuinely useful botanical intervention develops an undeserved reputation for inefficacy — a reputational externality generated by low-quality products that the high-quality manufacturers pay for in consumer scepticism.

A Practical Guide to Applying This Knowledge

For the Singaporean consumer who has read this far and wants to make an informed decision:

Demand eurycomanone specification on the label. Anything below 0.8% (or unspecified) in a water-soluble extract is below the clinical standard. This is non-negotiable.

Identify the extract trade name. Physta® and LJ100® are the extracts with the strongest human clinical evidence. If neither name appears, ask the retailer or manufacturer which extract is used and request the Certificate of Analysis.

Ask about the extraction and drying method. Freeze-dried aqueous extraction preserves the full bioactive spectrum including eurypeptides. Spray-dried or ethanol-extracted products are narrower preparations.

Do not conflate raw root powder with standardised extract. They are different products with different bioactive profiles, different batch-to-batch consistency, and different evidentiary bases. One is a traditional food supplement. The other is a clinically characterised botanical pharmaceutical.

Match dose to evidence. The clinical evidence base supports 200–400 mg daily of a standardised extract (Physta® equivalent), with 200 mg the most-replicated baseline and 400 mg the upper end of the routinely-evidenced daily window. Around 600 mg sits at the upper clinical ceiling for shorter-term, cycled use. Raw root powder doses are not interchangeable with extract doses.

Conclusion

The choice between raw Tongkat Ali and a standardised extract is not a choice between natural and artificial. It is a choice between uncontrolled variability and reproducible chemistry. In a clinical context — or for any consumer who wants to know that what they are taking will work the same way tomorrow as it did today — that distinction is everything.

The science of Tongkat Ali has advanced far enough to give consumers a precise, evidence-grounded standard to demand. The question is whether they know to demand it.

Now, they do.

Frequently Asked Questions

What is the difference between raw, crude, and standardised Tongkat Ali extract?

A raw herb equivalent (e.g., "5,000 mg root") tells you nothing about bioactive content. A crude extract is sold by ratio (1:50, 1:100, 1:200 — i.e. 100 kg or 200 kg of raw root yielding 1 kg of extract), and consumers often assume a higher ratio means a more potent product. is sold by ratio (1:50, 1:100, 1:200 — i.e. 100 kg or 200 kg of raw root yielding 1 kg of extract), and consumers often assume a higher ratio means a more potent product. The opposite is closer to the truth: extract ratios are largely marketing jargon, and a higher ratio frequently signals lower-quality source root or over-aggressive processing rather than greater potency. A standardised extract specifies the percentage of key bioactives such as eurycomanone — this is the only category that allows precise, reproducible dosing matched to clinical research. Physta®, for example, sits at around a 1:20 extraction ratio because its potency comes from preserving and quantifying bioactives, not from headline concentration.

Is hot-water extraction better than ethanol extraction for Tongkat Ali?

For most consumers, yes. Aqueous extraction — combined with freeze-drying — preserves the full bioactive ensemble, including the heat- and alcohol-sensitive eurypeptides that mediate Tongkat Ali's adaptogenic, cortisol-reducing effects. Ethanol extraction may produce a higher eurycomanone concentration on paper but strips out the eurypeptide fraction almost entirely, narrowing the therapeutic profile of the product. The peer-reviewed RCTs that established Tongkat Ali's evidence base were conducted predominantly on aqueous freeze-dried extracts.

Can I just boil raw Tongkat Ali root at home?

You can, and the resulting bitter decoction is chemically valid as a traditional preparation — but you cannot expect clinically reproducible outcomes from it. Raw root potency varies by up to 340% across geographically adjacent samples (Mohd Yusoff et al., 2020), which means your home preparation will be dramatically more or less potent than your neighbour's even with identical recipe. A standardised extract exists precisely to remove this variable.

What does "0.8% eurycomanone" actually mean?

It means that 0.8% of the dry weight of the finished extract is composed of the quassinoid eurycomanone — the principal bioactive responsible for Tongkat Ali's testosterone-modulating effects. This is the minimum threshold associated with the clinically validated standardised extracts. A 200 mg capsule of a 0.8% eurycomanone extract therefore delivers approximately 1.6 mg of eurycomanone, which is the bioactive quantity that the published Physta® RCTs are based on.

How much standardised Tongkat Ali extract should I take per day?

The evidence-backed daily range for a standardised extract is 200–400 mg, with 200 mg the most-replicated baseline across Physta® RCTs and 400 mg the upper end of the routinely-evidenced daily window. Around 600 mg sits at the upper clinical ceiling for shorter-term, cycled use; doses above 600 mg are experimental and lack supporting long-term human data.

References

Biotropics Malaysia. (2023). Physta® freeze-dried water extract of Eurycoma longifolia: Scientific dossier and clinical evidence summary. Biotropics Malaysia Berhad. https://www.biotropics.com.my/physta

Chan, K. L., Low, B. S., Teh, C. H., & Das, P. K. (2009). The effect of Eurycoma longifolia on sperm quality of male rats. Natural Product Communications, 4(10), 1331–1336. https://doi.org/10.1177/1934578X0900401005

George, A., & Henkel, R. (2014). Phytoandrogenic properties of Eurycoma longifolia as a natural alternative to testosterone replacement therapy. Andrologia, 46(7), 708–721. https://doi.org/10.1111/and.12214

Henkel, R. R., Wang, R., Bassett, S. H., Chen, T., Liu, N., Zhu, Y., & Tambi, M. I. B. M. (2014). Tongkat Ali as a potential herbal supplement for physically active male and female seniors — A pilot study. Phytotherapy Research, 28(4), 544–550. https://doi.org/10.1002/ptr.5017

Ismail, S. B., Wan Mohammad, W. M. Z., George, A., Nik Hussain, N. H., Musthapa Kamal, Z. M., & Liske, E. (2012). Randomized clinical trial on the use of PHYSTA® freeze-dried water extract of Eurycoma longifolia for the improvement of quality of life and sexual well-being in men. Evidence-Based Complementary and Alternative Medicine, 2012, 429268. https://doi.org/10.1155/2012/429268

Khanijo, T., & Jiraungkoorskul, W. (2016). Review ergogenic effect of long jack, Eurycoma longifolia. Pharmacognosy Reviews, 10(20), 139–142. https://doi.org/10.4103/0973-7847.194048

Low, B. S., Choi, S. B., Abdul Wahab, H., Das, P. K., & Chan, K. L. (2013). Eurycomanone, the major quassinoid in Eurycoma longifolia root extract, exerts its effects on steroidogenesis at the level of steroidogenic acute regulatory protein. Journal of Ethnopharmacology, 150(2), 648–655. https://doi.org/10.1016/j.jep.2013.09.011

Mohd Yusoff, N. A., Teh, B. P., Abd Wahab, N., Mohamad Taufik, M. F., Zainudin, N. A., Muhammad Nizzam, N. A. R., Abd Rashid, N. N., & Mohd Isa, M. H. (2020). Variation in eurycomanone content of Eurycoma longifolia Jack across different geographical locations in Malaysia. Industrial Crops and Products, 145, 112147. https://doi.org/10.1016/j.indcrop.2019.112147

Talbott, S. M., Talbott, J. A., George, A., & Pugh, M. (2013). Effect of Tongkat Ali on stress hormones and psychological mood state in moderately stressed subjects. Journal of the International Society of Sports Nutrition, 10(1), 28. https://doi.org/10.1186/1550-2783-10-28

Tambi, M. I. B. M., Imran, M. K., & Henkel, R. R. (2012). Standardised water-soluble extract of Eurycoma longifolia, Tongkat Ali, as testosterone booster for managing men with late-onset hypogonadism. Andrologia, 44(Suppl. 1), 226–230. https://doi.org/10.1111/j.1439-0272.2011.01168.x

Thu, H. E., Mohamed, I. N., Hussain, Z., Jayusman, P. A., & Shuid, A. N. (2017). Eurycoma longifolia as a potential alternative to testosterone for the treatment of male hypogonadism: A systematic review. Evidence-Based Complementary and Alternative Medicine, 2017, 3846029. https://doi.org/10.1155/2017/3846029